Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mary G. Blanton"'
Autor:
Maria N. Garnovskaya, Mary G. Blanton, Richard H. Weisbart, Nancy L. Goicochea, Michael B. Lilly, Grace Chan
Publikováno v:
Protein engineering, designselection : PEDS. 30(12)
Castration-resistant prostate cancer cells exhibit continued androgen receptor signaling in spite of low levels of ligand. Current therapies to block androgen receptor signaling act by inhibiting ligand production or binding. We developed bispecific
Autor:
Paul A. Blichmann, Alisha Joyner, P. Darwin Bell, Mary G. Blanton, Mi-Hye Lee, Sonya D. Coaxum, Takamitsu Saigusa, Tanjina Akter, Louis M. Luttrell, Maria N. Garnovskaya, John R. Raymond
Publikováno v:
American Journal of Physiology-Cell Physiology. 307:C554-C560
Epidermal growth factor (EGF) is linked to the pathogenesis of polycystic kidney disease (PKD). We explored signaling pathways activated by EGF in orpk cilia (−) collecting duct cell line derived from a mouse model of PKD (hypomorph of the Tg737/ I
Autor:
Mary G. Blanton, Patricia H. Janak, M. Foster Olive, Megan P. Hicks, Andrew J. Mcgeehan, Jennifer R. Kinder, Lacey L. Sahuque, Erika F. Kullberg
Publikováno v:
Psychopharmacology. 186:122-132
Corticotropin-releasing factor (CRF) produces anxiety-like and aversive effects when infused directly into the various regions of the brain, including the bed nucleus of the stria terminalis (BNST). However, the CRF receptor subtypes within the BNST
Autor:
P. Darwin Bell, Maria N Garnovskaya, Tanjina Akter, John R. Raymond, Mary G Blanton, Sonya D. Coaxum, Marlene A Bunni
Publikováno v:
The FASEB Journal. 25
Autor:
Grace Chan, Michael B. Lilly, Maria N. Garnovskaya, Mary G. Blanton, Richard H. Weisbart, Nancy L. Goicochea
Publikováno v:
Cancer Research. 75:642-642
Androgen receptor (AR) plays a critical role in the development and progression of prostate cancer (PCa). Current therapies target the ligand-binding domain (LBD) of AR by inhibiting production or binding of ligand. In castration-resistant PCa (CRPC)